Sale of 16.5 million units slated to fund general corporate purposes
By Devika Patel
Knoxville, Tenn., Dec. 1 – Miraculins Inc. said it settled a C$1.32 million non-brokered private placement of units on Nov. 27.
The company sold 16.5 million units of one common share and one warrant at C$0.08 per unit.
Each two-year warrant is exercisable at C$0.105, a 25% discount to the Nov. 26 closing share price of C$0.14.
Proceeds will be used for general corporate purposes.
Based in Winnipeg, Man., Miraculins is a medical diagnostic development company focused on non-invasive tests for unmet clinical needs.
| Issuer: | Miraculins Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$1.32 million
|
| Units: | 16.5 million
|
| Price: | C$0.08
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | C$0.105
|
| Settlement date: | Nov. 27
|
| Stock symbol: | TSX Venture: MOM
|
| Stock price: | C$0.14 at close Nov. 26
|
| Market capitalization: | C$2.83 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
